Search all medical codes

Chromogenic substrate assay

CPT4 code

Name of the Procedure:

Chromogenic Substrate Assay

  • Also known as Chromogenic Assay or Colorimetric Assay.

Summary

A Chromogenic Substrate Assay is a laboratory method used to measure the activity of specific enzymes by using substrates that release a colored product when cleaved by the enzyme. This color change can be measured to determine enzyme activity levels.

Purpose

The assay is designed to measure the activity of enzymes related to blood clotting and other physiological processes. It aids in diagnosing conditions like hemophilia, monitoring anticoagulant therapy, and other disorders where enzyme quantification is necessary.

Indications

  • Bleeding disorders (e.g., hemophilia, von Willebrand disease)
  • Monitoring anticoagulant therapy (e.g., heparin)
  • Diagnosing thrombotic disorders
  • Pre-surgical evaluation of bleeding risk

Preparation

  • No specific fasting required.
  • Patients on anticoagulant or other specific medications may need adjustment as instructed by their healthcare provider.
  • Routine blood tests may be needed to ensure overall health status is suitable.

Procedure Description

  1. A blood sample is collected from the patient's vein.
  2. The sample is processed to obtain plasma.
  3. The plasma is mixed with a chromogenic substrate specific to the enzyme being measured.
  4. The mixture is incubated under controlled conditions.
  5. The enzyme activity cleaves the substrate, releasing a colored product.
  6. The intensity of the color, proportional to enzyme activity, is measured using a spectrophotometer.

Tools: Spectrophotometer, test tubes, pipettes, chromogenic substrates.

No anesthesia or sedation is necessary.

Duration

The procedure, including blood sample collection and the assay, typically takes about 1-2 hours.

Setting

Performed in a laboratory setting, either in hospitals or specialized diagnostic clinics.

Personnel

  • Phlebotomist for blood sample collection.
  • Laboratory technicians and pathologists for the assay and interpretation of results.

Risks and Complications

  • Minor risks related to blood draw like bruising or lightheadedness.
  • Rare risks of inaccurate results due to sample contamination or improper handling.

Benefits

  • Accurate and specific measure of enzyme activity.
  • Helps in diagnosing and managing coagulation disorders effectively.
  • Results can be available within a few hours to a day.

Recovery

  • No significant recovery time needed post blood draw.
  • Patients can resume normal activities immediately.
  • Follow-up with a healthcare provider as advised to discuss results.

Alternatives

  • Immunoassays: Measure enzyme levels using antibodies.
  • Functional assays: Assess overall clotting function rather than specific enzymes.
  • Genetic testing: Identifies underlying genetic mutations in coagulation disorders.

Pros and cons of alternatives:

  • Immunoassays may be more specific but less sensitive to enzyme activity.
  • Functional assays provide broader information but may lack specificity.
  • Genetic testing offers conclusive diagnosis of hereditary conditions but is more expensive and not always necessary.

Patient Experience

  • During the procedure: Minor discomfort during blood draw.
  • After the procedure: Minimal to no side effects, sometimes slight bruising at the blood draw site.
  • Pain management: Generally, not needed due to the minimally invasive nature of the procedure.

Medical Policies and Guidelines for Chromogenic substrate assay

Related policies from health plans

Similar Codes